Skip to content
value.today
Bone Health Technologies, Inc. logo

Bone Health Technologies, Inc.

Total raised
$3 M
1 round on record
Latest round
$3 M
Apr 2023
First round on record
Apr 2023
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bone Health Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$3 MNo. 1$2 to $10 million

Bone Health Technologies, Inc.: Raise no. 1, Apr 2023

Investors in this round

22 investors had bought by the notice of May 9, 2023: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Laura Yecies · Executive Officer, Director
  • John Osborne · Director
  • Kian Beyzavi · Director
  • Marcie Hamilton · Director
  • Pamela Peeke · Director
  • Sam Goldberger · Director
  • Shane Mangrum · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Laura Yecies, Ceo. Source: SEC Form D, newest notice filed May 9, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bone Health Technologies, Inc. reported revenue of $85,542 for its most recent fiscal year (filed Nov 2025), up from $0 the year before.

    SEC Form C · Nov 2025

  • The direct cost of what it sold was $42,439, so 50% of its revenue was left after those costs.

    SEC Form C · Nov 2025

  • Net loss for the same year: $2.50 million.

    SEC Form C · Nov 2025

  • Bone Health Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2023

In its own words

How the company describes itself to search engines on its website, word for word.

“Osteoboost is the first and only FDA-cleared wearable therapy for osteopenia—clinically proven to reduce bone loss in the spine. Order online with prescription.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Bone Health Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bone Health Technologies, Inc.
NameRoleNamed in
Laura YeciesExecutive officerMay 2023
John OsborneDirectorMay 2023
Kian BeyzaviDirectorMay 2023
Laura YeciesDirectorMay 2023
Marcie HamiltonDirectorMay 2023
Pamela PeekeDirectorMay 2023
Sam GoldbergerDirectorMay 2023
Shane MangrumDirectorMay 2023